Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy

The aim of this study was to evaluate if bone marrow (BM) SUVmax measured on pre-treatment 18F-FDG PET/CT predicts the clinical outcome of locally advanced cervical cancer (LACC). We recruited retrospectively patients with LACC who underwent staging 18F-FDG PET/CT and had baseline blood tests, then...

Full description

Saved in:
Bibliographic Details
Published in:Oncoimmunology
Main Authors: Seban, Romain-David, Robert, Charlotte, Dercle, Laurent, Yeh, Randy, Dunant, Ariane, Reuze, Sylvain, Schernberg, Antoine, Sun, Roger, Mignot, Fabien, Terroir, Marie, Schlumberger, Martin, Haie-Meder, Christine, Chargari, Cyrus, Deutsch, Eric
Format: Artigo
Language:Inglês
Published: Taylor & Francis 2019
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6492982/
https://ncbi.nlm.nih.gov/pubmed/31069132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1574197
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items